메뉴 건너뛰기




Volumn 100, Issue 9, 2011, Pages 745-753

Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: Lessons from Pre-RELAX-AHF

Author keywords

Clinical trials; Heart failure; Phase II; Statistics

Indexed keywords

RELAXIN;

EID: 80054771951     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0304-5     Document Type: Article
Times cited : (13)

References (18)
  • 1
    • 66949126764 scopus 로고    scopus 로고
    • Are BNP changes during hospitalization for heart failure a reliable surrogate for predicting the effects of therapies on post-discharge mortality?
    • 19539145 10.1016/j.jacc.2009.01.075 1:CAS:528:DC%2BD1MXovFShtLs%3D
    • M Gheorghiade PS Pang 2009 Are BNP changes during hospitalization for heart failure a reliable surrogate for predicting the effects of therapies on post-discharge mortality? J Am Coll Cardiol 53 25 2349 2352 19539145 10.1016/j.jacc.2009.01.075 1:CAS:528:DC%2BD1MXovFShtLs%3D
    • (2009) J Am Coll Cardiol , vol.53 , Issue.25 , pp. 2349-2352
    • Gheorghiade, M.1    Pang, P.S.2
  • 2
    • 67651174313 scopus 로고    scopus 로고
    • Hotline sessions presented at the American College of Cardiology Congress 2009
    • 19430713 10.1007/s00392-009-0023-3
    • LS Maier M Baumhakel M Bohm 2009 Hotline sessions presented at the American College of Cardiology Congress 2009 Clin Res Cardiol 98 6 345 352 19430713 10.1007/s00392-009-0023-3
    • (2009) Clin Res Cardiol , vol.98 , Issue.6 , pp. 345-352
    • Maier, L.S.1    Baumhakel, M.2    Bohm, M.3
  • 3
    • 65249190276 scopus 로고    scopus 로고
    • Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): A multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study
    • 19329178 10.1016/S0140-6736(09)60622-X 1:CAS:528:DC%2BD1MXltVCqtbk%3D
    • JR Teerlink M Metra GM Felker P Ponikowski AA Voors BD Weatherley, et al. 2009 Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study Lancet 373 9673 1429 1439 19329178 10.1016/S0140-6736(09)60622-X 1:CAS:528:DC%2BD1MXltVCqtbk%3D
    • (2009) Lancet , vol.373 , Issue.9673 , pp. 1429-1439
    • Teerlink, J.R.1    Metra, M.2    Felker, G.M.3    Ponikowski, P.4    Voors, A.A.5    Weatherley, B.D.6
  • 5
    • 44349154267 scopus 로고    scopus 로고
    • A Global Ranking Approach to End Points in Trials of Mechanical Circulatory Support Devices
    • DOI 10.1016/j.cardfail.2008.01.009, PII S1071916408000274
    • GM Felker KJ Anstrom JG Rogers 2008 A global ranking approach to end points in trials of mechanical circulatory support devices J Card Fail 14 5 368 372 18514927 10.1016/j.cardfail.2008.01.009 (Pubitemid 351749834)
    • (2008) Journal of Cardiac Failure , vol.14 , Issue.5 , pp. 368-372
    • Felker, G.M.1    Anstrom, K.J.2    Rogers, J.G.3
  • 6
    • 67649977368 scopus 로고    scopus 로고
    • End points for clinical trials in acute heart failure syndromes
    • 19520247 10.1016/j.jacc.2008.12.079
    • LA Allen AF Hernandez CM O'Connor GM Felker 2009 End points for clinical trials in acute heart failure syndromes J Am Coll Cardiol 53 24 2248 2258 19520247 10.1016/j.jacc.2008.12.079
    • (2009) J Am Coll Cardiol , vol.53 , Issue.24 , pp. 2248-2258
    • Allen, L.A.1    Hernandez, A.F.2    O'Connor, C.M.3    Felker, G.M.4
  • 7
    • 29444454634 scopus 로고    scopus 로고
    • Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE
    • DOI 10.1016/j.ejheart.2005.12.003, PII S1388984205003466
    • JG Cleland N Freemantle AP Coletta AL Clark 2006 Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE Eur J Heart Fail 8 1 105 110 16387630 10.1016/j.ejheart.2005.12.003 1:CAS:528:DC%2BD28XkvFWn (Pubitemid 43012109)
    • (2006) European Journal of Heart Failure , vol.8 , Issue.1 , pp. 105-110
    • Cleland, J.G.F.1    Freemantle, N.2    Coletta, A.P.3    Clark, A.L.4
  • 8
    • 52949105070 scopus 로고    scopus 로고
    • The PROTECT pilot study: A randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment
    • 18926433 10.1016/j.cardfail.2008.08.010 1:CAS:528:DC%2BD1cXhtFOrtLvK
    • G Cotter HC Dittrich BD Weatherley DM Bloomfield CM O'Connor M Metra, et al. 2008 The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment J Card Fail 14 8 631 640 18926433 10.1016/j.cardfail.2008.08.010 1:CAS:528:DC%2BD1cXhtFOrtLvK
    • (2008) J Card Fail , vol.14 , Issue.8 , pp. 631-640
    • Cotter, G.1    Dittrich, H.C.2    Weatherley, B.D.3    Bloomfield, D.M.4    O'Connor, C.M.5    Metra, M.6
  • 9
    • 77957730950 scopus 로고    scopus 로고
    • Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure
    • 20925544 10.1056/NEJMoa0912613
    • BM Massie CM O'Connor M Metra P Ponikowski JR Teerlink G Cotter, et al. 2010 Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure N Engl J Med 363 15 1419 1428 20925544 10.1056/NEJMoa0912613
    • (2010) N Engl J Med , vol.363 , Issue.15 , pp. 1419-1428
    • Massie, B.M.1    O'Connor, C.M.2    Metra, M.3    Ponikowski, P.4    Teerlink, J.R.5    Cotter, G.6
  • 11
    • 0021666221 scopus 로고
    • Procedures for comparing samples with multiple endpoints
    • 6534410 10.2307/2531158
    • PC O'Brien 1984 Procedures for comparing samples with multiple endpoints Biometrics 40 4 1079 1087 6534410 10.2307/2531158
    • (1984) Biometrics , vol.40 , Issue.4 , pp. 1079-1087
    • O'Brien, P.C.1
  • 12
    • 0025882782 scopus 로고
    • Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate
    • 1912258 10.2307/2532142 1:STN:280:DyaK38%2FgtlWjuw%3D%3D
    • W Lehmacher G Wassmer P Reitmeir 1991 Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate Biometrics 47 2 511 521 1912258 10.2307/2532142 1:STN:280:DyaK38%2FgtlWjuw%3D%3D
    • (1991) Biometrics , vol.47 , Issue.2 , pp. 511-521
    • Lehmacher, W.1    Wassmer, G.2    Reitmeir, P.3
  • 13
    • 64949097265 scopus 로고    scopus 로고
    • Advancing care for acute heart failure-no time to relax
    • 19329180 10.1016/S0140-6736(09)60653-X
    • AF Hernandez CB Granger 2009 Advancing care for acute heart failure-no time to relax Lancet 373 9673 1401 1402 19329180 10.1016/S0140-6736(09)60653-X
    • (2009) Lancet , vol.373 , Issue.9673 , pp. 1401-1402
    • Hernandez, A.F.1    Granger, C.B.2
  • 14
    • 77951683693 scopus 로고    scopus 로고
    • Sample size calculations for crossover thorough QT studies: Satisfaction of regulatory threshold and assay sensitivity
    • 20358438 10.1080/10543400903582000
    • SP Anand SC Murray GG Koch 2010 Sample size calculations for crossover thorough QT studies: satisfaction of regulatory threshold and assay sensitivity J Biopharm Stat 20 3 587 603 20358438 10.1080/10543400903582000
    • (2010) J Biopharm Stat , vol.20 , Issue.3 , pp. 587-603
    • Anand, S.P.1    Murray, S.C.2    Koch, G.G.3
  • 15
    • 77951891036 scopus 로고    scopus 로고
    • Clinical trials of pharmacological therapies in acute heart failure syndromes: Lessons learned and directions forward
    • 20233993 10.1161/CIRCHEARTFAILURE.109.893222
    • GM Felker PS Pang KF Adams JG Cleland G Cotter K Dickstein, et al. 2010 Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward Circ Heart Fail 3 2 314 325 20233993 10.1161/CIRCHEARTFAILURE.109.893222
    • (2010) Circ Heart Fail , vol.3 , Issue.2 , pp. 314-325
    • Felker, G.M.1    Pang, P.S.2    Adams, K.F.3    Cleland, J.G.4    Cotter, G.5    Dickstein, K.6
  • 16
    • 77957139942 scopus 로고    scopus 로고
    • Acute heart failure clinical drug development: From planning to proof of activity to Phase III
    • 20881385 10.1159/000318048
    • G Cotter AA Voors BD Weatherley PS Pang JR Teerlink G Filippatos, et al. 2010 Acute heart failure clinical drug development: from planning to proof of activity to Phase III Cardiology 116 4 292 301 20881385 10.1159/000318048
    • (2010) Cardiology , vol.116 , Issue.4 , pp. 292-301
    • Cotter, G.1    Voors, A.A.2    Weatherley, B.D.3    Pang, P.S.4    Teerlink, J.R.5    Filippatos, G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.